openPR Logo
Press release

Metal Hip Implant Failures Could Translate to Higher Taxes, Increased Health Care Costs

12-30-2011 07:09 AM CET | Politics, Law & Society

Press release from: Nadrich & Cohen LLP

Nadrich & Cohen LLP reports that medical and legal experts are predicting that taxes, insurance costs and health care costs will skyrocket as more artificial hip implant devices fail.

Los Angeles, CA, December 28, 2011 – The report is based on a recent New York Times article, which profiled several individuals who received a metal-on-metal hip replacement system. One of the recipients profiled is currently facing nearly $500,000 in medical bills after his metal hip implant failed and he required additional surgery to correct the problem. The hip system failure has rendered him unable to perform even the simplest tasks and he is contemplating filing a personal injury lawsuit against the device’s manufacturer, Johnson & Johnson.

Should he file suit, his lawsuit will become one of thousands already filed against metal hip manufacturers, including Wright Medical Technologies, Inc., Smith & Nephew, Zimmer Holdings and Johnson & Johnson’s DePuy Orthopedics. DePuy alone faces an estimated 3,500 lawsuits filed by patients who received its now recalled ASR artificial hip and another 560 who received one of the company’s Pinnacle hip systems. Many of the plaintiffs in the lawsuits, which have been filed in state and federal courts across the country, are petitioning the U.S. Panel on Multidistrict Litigation to consolidate some of the cases for pretrial proceedings.

According to the NYT article, insurance companies have already begun informing plaintiffs that they will attempt to recover their expenses from any settlements that are received. It is also likely that Medicare will attempt to recover some of the cost from individuals who received a faulty hip implant at their expense. A new law is scheduled to take effect next year which would allow the organization greater ease in recovering taxpayer money used to treat individuals harmed by defective medical devices or prescription drugs. This could translate to an increase in taxes, which would place even more pressure on those already struggling in the difficult economy.

The article acknowledges that there is no official data on the number of metal hip implants that failed because there are no formal tracking registries that maintain this information. With an estimated 90,000 patients receiving an all-metal implant each year, it is likely that the number of personal injury lawsuits stemming from these devices is expected to grow.

Anyone who has experienced serious complications after receiving a metal hip replacement is urged to contact an experienced personal injury attorney to discuss their case. The law firm of Nadrich & Cohen LLP is currently working with patients in all 50 states to resolve their personal injury claim. Concerned hip implant recipients can schedule a free initial case evaluation by calling 1-800-722-0765 or by visiting www.DePuyHipReplacementLawyers.net.

Nadrich & Cohen LLP is a national law firm specializing in representing clients in every state who’ve been injured by defective medical devices, harmful prescription drugs, faulty products, car accidents, motorcycle accidents and dog bites.

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd
Suite 1250
Los Angeles, CA 90025
800-718-4658
www.PersonalInjuryLawCal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metal Hip Implant Failures Could Translate to Higher Taxes, Increased Health Care Costs here

News-ID: 205599 • Views:

More Releases from Nadrich & Cohen LLP

Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation. Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots. Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants. Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems. The two-day panel, which is expected
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country. Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the

All 5 Releases


More Releases for Johnson

Sarcoma Treatment Market Is Booming Worldwide 2025-2032 | Amgen Inc., Johnson & …
Coherent Market Insights has released a statistical report titled "Sarcoma Treatment Market Recent Trends, In-depth Analysis, Size, and Forecast 2025-2032." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, presence, market share, pricing, locations of production facilities, and the
Siltuximab Market Analysis By Top Keyplayers - Johnson & Johnson
The "Siltuximab Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Siltuximab Market, 2024-2031 Verified Market Research's most recent report, "Siltuximab Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry
Artificial Limbs and Joints Market Expected to reach a Hugh Growth by 2031 | Art …
Artificial Limbs and Joints Market is the focal point of DataM Intelligence's latest market research report, offering a comprehensive analysis of this dynamic sector. This in-depth study goes beyond a basic overview, exploring the intricate dynamics that shape the market. By examining regional trends, demand patterns, and potential breakthroughs, DataM Intelligence aims to empower businesses and stakeholders with valuable insights for navigating the evolving landscape. The insights from this report
Artificial Limbs and Joints Industry to Witness Massive Growth (2024-2031) | Art …
Artificial Limbs and Joints Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future. Will the Artificial Limbs and Joints market emerge as the sector's next great thing? To discover the answer, look at the Artificial Limbs and
Ebola Vaccine Market | CanSino Biologics Inc, Johnson & Johnson, Merck,
The global ebola vaccine market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the ebola vaccine market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Medical Devices for Diagnostics in Vitro Market is Thriving Worldwide with Top K …
​Market Overview - According To A Recent Report Published By QYResearch, The Global Medical Devices for Diagnostics in Vitro Market Is Heading Towards The Inclined Path Of Growth With An Exceptional Growth Rate Over The Forecast Period Of 2023-2029. The Report Published Covers All The Aspects Of The Medical Devices for Diagnostics in Vitro Industry, Starting From The Industry Standard, Segments In Which The Industry Operates, Regional